Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of crushed deferasirox film-coated tablets in young pediatric patients with transfusional iron overload
2016-003482-25Phase 4Completed
- Sponsor
- Novartis
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of deferasirox in transfusional hemosiderosis, Transfusional Siderosis and hemosiderosis, sponsored by Novartis. Primary endpoint: Selected gastrointestinal disorders incidence. Started Oct 2017; status: completed.
02
Drugs
deferasirox
03
Conditions
transfusional hemosiderosisTransfusional Siderosishemosiderosis
Beyond the preview
Go deeper on 2016-003482-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003482-25.